伊莱利将以23亿美元收购阿贾克斯治疗公司, 以开发血液癌症药物. Eli Lilly to acquire Ajax Therapeutics for $2.3B for blood cancer drug development.

伊利莉将以23亿美元收购阿贾克斯治疗公司, 重点开发下一代血液癌症药物. Eli Lilly will acquire Ajax Therapeutics for up to $2.3 billion, focusing on developing a next-generation drug for blood cancers. 协议的目标是治疗旨在克服对当前疗法的耐药性, The deal targets a treatment designed to overcome resistance to current therapies, with clinical data expected later this year.